Literature DB >> 9570145

Steroidogenic factor-1 (SF-1) and the regulation of expression of luteinising hormone and follicle stimulating hormone b-subunits in the sheep anterior pituitary in vivo.

P Brown1, A S Mcneilly.   

Abstract

Luteinising hormone (LH) and follicle stimulating hormone (FSH) comprise a common alpha-subunit and hormone-specific beta-subunit, are expressed in gonadotroph cells of the anterior pituitary and during the sheep oestrous cycle, are regulated by gonadotrophin releasing hormone (GnRH), ovarian peptides and steroids. Transcription factor steroidogenic factor-1 (SF-1) transactivates the common alpha-subunit and LH beta subunit in other species. We investigated whether SF-1 regulates beta-subunit expression and the regulation of SF-1 expression in vivo in sheep. Immunocytochemistry co-localised SF-1, LH and FSH to sheep pituitary gonadotrophs and electrophoretic mobility shift assays (EMSA) demonstrated that SF-1 bound to the LH beta promoter in vitro. No SF-1 DNA binding site was found in the FSH beta promoter. No difference in mean levels of SF-1, FSH beta, LH beta and GnRHr mRNA was measured between the luteal and follicular phases of the oestrous cycle. However SF-1 mRNA levels were correlated to those of LH beta in individual luteal phase animals (r = 0.88, p < 0.05), when the transcription rate of LH beta was significantly higher (p < 0.01). GnRH antagonist treatment of luteal animals did not produce a significant reduction in mRNA levels of LH beta, SF-1 and FSH beta. Administering oestradiol benzoate with GnRH antagonist reduced levels of SF-1 and FSH beta mRNA from luteal values (p < 0.005). We conclude that: (1) expression of SF-1 is not solely dependent on GnRH and is downregulated by oestradiol; (2) the LH beta transcription rate is increased during the luteal phase but is not related to levels of LH beta or SF-1 mRNA; and (3) SF-1 does not appear to directly regulate expression of FSH beta, but may regulate expression indirectly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9570145     DOI: 10.1016/s1357-2725(97)00082-4

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  Proline-rich tyrosine kinase 2 mediates gonadotropin-releasing hormone signaling to a specific extracellularly regulated kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene.

Authors:  Stuart Maudsley; Zvi Naor; David Bonfil; Lindsay Davidson; Dimitra Karali; Adam J Pawson; Rachel Larder; Caroline Pope; Nancy Nelson; Robert P Millar; Pamela Brown
Journal:  Mol Endocrinol       Date:  2007-02-27

2.  Identification of Smad Response Elements in the Promoter of Goldfish FSHβ Gene and Evidence for Their Mediation of Activin and GnRH Stimulation of FSHβ Expression.

Authors:  Man-Tat Lau; Sze-Wah Lin; Wei Ge
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-27       Impact factor: 5.555

3.  Divergent activity of the gonadotropin-releasing hormone receptor gene promoter among genetic lines of pigs is partially conferred by nuclear factor (NF)-B, specificity protein (SP)1-like and GATA-4 binding sites.

Authors:  Emily A McDonald; Jacqueline E Smith; Rebecca A Cederberg; Brett R White
Journal:  Reprod Biol Endocrinol       Date:  2016-06-29       Impact factor: 5.211

Review 4.  Genetic regulation of pituitary gland development in human and mouse.

Authors:  Daniel Kelberman; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  Endocr Rev       Date:  2009-10-16       Impact factor: 19.871

5.  SF-1 a key player in the development and differentiation of steroidogenic tissues.

Authors:  Pierre Val; Anne-Marie Lefrançois-Martinez; Georges Veyssière; Antoine Martinez
Journal:  Nucl Recept       Date:  2003-09-18

6.  Gonadotropin-releasing hormone regulates expression of the DNA damage repair gene, Fanconi anemia A, in pituitary gonadotroph cells.

Authors:  Rachel Larder; Lynda Chang; Michael Clinton; Pamela Brown
Journal:  Biol Reprod       Date:  2004-05-05       Impact factor: 4.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.